Creative Planning’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
Other funds holding NUVB
DC
VCM
OFM
LCM
DFO
Creative Planning's NUVB Position: Q1 2026 in Review
Creative Planning reduced its Nuvation Bio (NUVB) stake by 5.8% in Q1 2026, selling an estimated $35K and leaving 101,424 shares worth $435K. The position accounts for ﹤0.01% of the portfolio, ranked #3135.
Creative Planning first reported a position in NUVB in Q1 2021 and has held it in 15 quarters since. The position peaked at $965K in Q4 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.
- Creative Planning held 101,424 shares of Nuvation Bio worth $435K as of Q1 2026.
- Creative Planning sold 6,290 Nuvation Bio shares in Q1 2026, an estimated $35K.
- Nuvation Bio made up ﹤0.01% of Creative Planning's portfolio in Q1 2026, its #3135 holding.
- Creative Planning first reported a position in Nuvation Bio in Q1 2021 and has held it in 15 quarters since.
- Creative Planning's Nuvation Bio position peaked at $965K in Q4 2025.
- 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.
Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.